| Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy DG DeNardo, DJ Brennan, E Rexhepaj, B Ruffell, SL Shiao, SF Madden, ... Cancer discovery 1 (1), 54-67, 2011 | 1869 | 2011 |
| Macrophages as regulators of tumour immunity and immunotherapy DG DeNardo, B Ruffell Nature Reviews Immunology 19 (6), 369-382, 2019 | 1584 | 2019 |
| Macrophages and therapeutic resistance in cancer B Ruffell, LM Coussens Cancer cell 27 (4), 462-472, 2015 | 1348 | 2015 |
| Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells B Ruffell, D Chang-Strachan, V Chan, A Rosenbusch, CMT Ho, N Pryer, ... Cancer cell 26 (5), 623-637, 2014 | 957 | 2014 |
| Differential macrophage programming in the tumor microenvironment B Ruffell, NI Affara, LM Coussens Trends in immunology 33 (3), 119-126, 2012 | 957 | 2012 |
| Dendritic cells and cancer immunity A Gardner, B Ruffell Trends in immunology 37 (12), 855-865, 2016 | 777 | 2016 |
| Leukocyte composition of human breast cancer B Ruffell, A Au, HS Rugo, LJ Esserman, ES Hwang, LM Coussens Proceedings of the National Academy of Sciences 109 (8), 2796-2801, 2012 | 549 | 2012 |
| Bruton tyrosine kinase–dependent immune cell cross-talk drives pancreas cancer AJ Gunderson, MM Kaneda, T Tsujikawa, AV Nguyen, NI Affara, B Ruffell, ... Cancer discovery 6 (3), 270-285, 2016 | 454 | 2016 |
| CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells DC Strachan, B Ruffell, Y Oei, MJ Bissell, LM Coussens, N Pryer, ... Oncoimmunology 2 (12), e26968, 2013 | 403 | 2013 |
| MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles HE Daldrup-Link, D Golovko, B Ruffell, DG DeNardo, R Castaneda, ... Clinical Cancer Research 17 (17), 5695-5704, 2011 | 326 | 2011 |
| Dendritic cells and their role in immunotherapy A Gardner, Á de Mingo Pulido, B Ruffell Frontiers in immunology 11, 531484, 2020 | 318 | 2020 |
| Lymphocytes in cancer development: polarization towards pro-tumor immunity B Ruffell, DG DeNardo, NI Affara, LM Coussens Cytokine & growth factor reviews 21 (1), 3-10, 2010 | 316 | 2010 |
| TIM-3 regulates CD103+ dendritic cell function and response to chemotherapy in breast cancer Á de Mingo Pulido, A Gardner, S Hiebler, H Soliman, HS Rugo, ... Cancer cell 33 (1), 60-74. e6, 2018 | 302 | 2018 |
| B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas NI Affara, B Ruffell, TR Medler, AJ Gunderson, M Johansson, S Bornstein, ... Cancer cell 25 (6), 809-821, 2014 | 302 | 2014 |
| HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma H Zheng, W Zhao, C Yan, CC Watson, M Massengill, M Xie, C Massengill, ... Clinical Cancer Research 22 (16), 4119-4132, 2016 | 296 | 2016 |
| TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy SL Shiao, B Ruffell, DG DeNardo, BA Faddegon, CC Park, LM Coussens Cancer immunology research 3 (5), 518-525, 2015 | 248 | 2015 |
| Role of CD44 and hyaluronan in neutrophil recruitment AI Khan, SM Kerfoot, B Heit, L Liu, G Andonegui, B Ruffell, P Johnson, ... The Journal of Immunology 173 (12), 7594-7601, 2004 | 240 | 2004 |
| CD44 and its role in inflammation and inflammatory diseases P Johnson, B Ruffell Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2009 | 236 | 2009 |
| Inflammation, ROS, and mutagenesis A El-Kenawi, B Ruffell Cancer cell 32 (6), 727-729, 2017 | 193 | 2017 |
| Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression O Maller, AP Drain, AS Barrett, S Borgquist, B Ruffell, I Zakharevich, ... Nature materials 20 (4), 548-559, 2021 | 154 | 2021 |
